R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析

◆英語タイトル:R1 RCM Inc (RCM) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1325
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

R1 RCM Inc (RCM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

R1 RCM Inc (R1), formerly Accretive Health Inc is a healthcare solutions company that offers Hospital and Health Systems solutions. The company’s RCM services helps to solve and transform revenue cycle performance challenges across health systems, hospitals and physician groups. The RCM Services comprise, bill preparation and collections, patient registration, medical treatment documentation and coding, insurance and benefit verification. Its PAS offering helps hospitals and medical facilities in complying with payer requirements for billing purposes. The company serves community healthcare systems, faith-based healthcare systems, ambulatory clinics, academic medical centers, physician practice groups and other healthcare organizations. R1 is headquartered in Chicago, Illinois, the US.

R1 RCM Inc Key Recent Developments

Feb 20,2020: R1 RCM reports fourth quarter and full year 2019 results
Jan 27,2020: R1 expands physician practice footprint with district medical group
Jan 22,2020: R1 RCM expands market reach with launch of revenue cycle management solution for large physician groups
Jan 09,2020: Rush University System for health selects R1 RCM for end-to-end revenue cycle management to drive performance excellence and accelerate innovation
Nov 05,2019: R1 RCM reports third quarter 2019 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
R1 RCM Inc – Key Facts
R1 RCM Inc – Key Employees
R1 RCM Inc – Key Employee Biographies
R1 RCM Inc – Major Products and Services
R1 RCM Inc – History
R1 RCM Inc – Company Statement
R1 RCM Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
R1 RCM Inc – Business Description
R1 RCM Inc – SWOT Analysis
SWOT Analysis – Overview
R1 RCM Inc – Strengths
R1 RCM Inc – Weaknesses
R1 RCM Inc – Opportunities
R1 RCM Inc – Threats
R1 RCM Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
R1 RCM Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 20, 2020: R1 RCM reports fourth quarter and full year 2019 results
Jan 27, 2020: R1 expands physician practice footprint with district medical group
Jan 22, 2020: R1 RCM expands market reach with launch of revenue cycle management solution for large physician groups
Nov 05, 2019: R1 RCM reports third quarter 2019 results
Oct 29, 2019: R1 RCM appoints Vijay Kotte as Executive Vice President, Physician Services
Sep 24, 2019: R1 RCM appoints Richard Evans as interim CFO
Aug 06, 2019: R1 RCM reports second quarter 2019 results
Jun 24, 2019: R1 showcases latest advancements in automated revenue cycle management at HFMA 2019 Annual Conference
Jun 11, 2019: R1 and Intermountain Healthcare host grand opening of new technology and innovation center
May 14, 2019: BJC HealthCare selects R1 RCM revenue integrity solutions to drive financial performance improvements and compliance
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
R1 RCM Inc, Key Facts
R1 RCM Inc, Key Employees
R1 RCM Inc, Key Employee Biographies
R1 RCM Inc, Major Products and Services
R1 RCM Inc, History
R1 RCM Inc, Subsidiaries
R1 RCM Inc, Key Competitors
R1 RCM Inc, Ratios based on current share price
R1 RCM Inc, Annual Ratios
R1 RCM Inc, Annual Ratios (Cont...1)
R1 RCM Inc, Annual Ratios (Cont...2)
R1 RCM Inc, Interim Ratios
R1 RCM Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
R1 RCM Inc, Performance Chart (2015 - 2019)
R1 RCM Inc, Ratio Charts

★海外企業調査レポート[R1 RCM Inc (RCM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PharmaZell GmbH:企業の戦略的SWOT分析
    PharmaZell GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vikas WSP Ltd (519307):企業の財務・戦略的SWOT分析
    Vikas WSP Ltd (519307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • BP Plc (BP.)-エネルギー分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Premaitha Health Plc (NIPT)-医療機器分野:企業M&A・提携分析
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Bioverativ Inc (BIVV):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Nichirei Corp (2871):企業の財務・戦略的SWOT分析
    Nichirei Corp (2871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Esperite NV (ESP):企業の財務・戦略的SWOT分析
    Esperite NV (ESP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Tereos:企業の戦略・SWOT・財務分析
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Vysarn Ltd (MHM):企業の戦略的SWOT分析
    Vysarn Ltd (MHM) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • National Beverage Corp.:企業の戦略・SWOT・財務情報
    National Beverage Corp. - Strategy, SWOT and Corporate Finance Report Summary National Beverage Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lincoln Electric Holdings, Inc.:戦略・SWOT・企業財務分析
    Lincoln Electric Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cipla Limited:企業の戦略・SWOT・財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sega Sammy Holdings Inc (6460):企業の財務・戦略的SWOT分析
    Sega Sammy Holdings Inc (6460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Abivax SA (ABVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • Echo Therapeutics Inc (ECTE)-医療機器分野:企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • Ricardo plc:戦略・SWOT・企業財務分析
    Ricardo plc - Strategy, SWOT and Corporate Finance Report Summary Ricardo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Santen Pharmaceutical Co Ltd (4536):製薬・医療:M&Aディール及び事業提携情報
    Summary Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacture and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for bacterial conjunctivitis, glaucoma, dry eye, Inflammation and others; OTC …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆